Cargando…

Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes

Detalles Bibliográficos
Autores principales:	Patil, Ankita A, Raveendra Murthy, Sowmya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333046/ https://www.ncbi.nlm.nih.gov/pubmed/35502098 http://dx.doi.org/10.4103/ijo.IJO_96_22

Ejemplares similares

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers
por: Li, Huixia, et al.
Publicado: (2022)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021)

Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study)
por: Agarwal, Pradeep, et al.
Publicado: (2022)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
por: Tsai, Hou-Ren, et al.
Publicado: (2021)

Short-Term Effects of Atropine 0.01% on the Structure and Vasculature of the Choroid and Retina in Myopic Chinese Children
por: Wang, Yuliang, et al.
Publicado: (2022)

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia
por: Kothari, Mihir, et al.
Publicado: (2020)

Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
por: Larkin, G. Luke, et al.
Publicado: (2019)

A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression
por: Kong, Xie-He, et al.
Publicado: (2021)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Effects of low-concentration atropine eye drops on the optical quality of the eyes in myopic children
por: Li, Weiran, et al.
Publicado: (2022)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
por: Cheng, Jingyi, et al.
Publicado: (2020)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes
por: Kothari, Mihir, et al.
Publicado: (2017)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2022)

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
por: Hansen, Niklas Cyril, et al.
Publicado: (2023)

Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial
por: Kinoshita, Nozomi, et al.
Publicado: (2020)

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting
por: Kaymak, Hakan, et al.
Publicado: (2021)

The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article)
por: Yu, Yan, et al.
Publicado: (2022)

Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial
por: Yu, Shiao, et al.
Publicado: (2022)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2023)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3f1rbedunkjuk8gok16hl4gbkn